Seller record · telehealth service · heandshemd.com
He & She MD
A telehealth service selling compounded and brand GLP-1 drugs, hormones and peptides. It names both filling pharmacies and its chief medical officer.
Passes 7 of 8 criteria. Recorded against Standard v1.1, August 2026.
Operating entity NextGen Telehealth Inc.
Dispositions at a glance
| Code | Criterion | Disposition |
|---|---|---|
| S1 | Prescriber requirement | PASS |
| S2 | Prescription gating | PASS |
| S3 | Pharmacy identification | PASS |
| S4 | Compounding disclosure | PASS |
| S5 | Analytical documentation | FAIL |
| S6 | Business address | PASS |
| S7 | Price disclosure | PASS |
| S8 | Enforcement status | PASS |
Evidence, criterion by criterion
What was read, where, and on what date, for each disposition in the table above.
S1PASSDr. Ozita Cooper, dual board-certified in obesity and emergency medicine, is named as chief medical officer on the home page.Source: heandshemd.com · read August 2026.
S2PASSThe order path was walked and stopped at the first intake screen, which asks about goals, health and lifestyle.Source: join.heandshemd.com/start-online-visit/glp1-offer · read August 2026.
S3PASSF&F Pharmacies Inc, doing business as Jungle Jim's Pharmacy, is named at 5484 Dixie Highway, Fairfield, Ohio 45014.Source: heandshemd.com · read August 2026.
S4PASSMedications in the GLP-1 program are produced in state-regulated pharmacies but not reviewed by the FDA, printed on the home page.Source: heandshemd.com · read August 2026.
S5FAILSterile compound batches are said to undergo third-party testing, and no test report is reachable on the pages read.Source: heandshemd.com · read August 2026.
S6PASSNextGen Telehealth Inc. at 7408 San Joaquin Plaza, Newport Beach, California 92660, printed in the privacy notice.Source: heandshemd.com/privacy-policy/ · read August 2026.
S7PASSInjectable semaglutide at 139 dollars per month for the first six months, renewing at 199 dollars per month afterward.Source: heandshemd.com · read August 2026.
S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index · read August 2026.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, brand GLP-1 drugs, NAD+, sermorelin, glutathione, testosterone, estradiol.
Dispositions recorded against Standard v1.1, August 2026. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.